Woodline Partners LP Annexon, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Annexon, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 3,430,160 shares of ANNX stock, worth $18.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,430,160

Previous 4,071,677 15.76%

Holding current value

$18.7 Million

Previous $20 Million 1.78%

% of portfolio

0.18%

Previous 0.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.49 - $7.2 $2.88 Million - $4.62 Million	-641,517 Reduced 15.76%	3,430,160 $20.3 Million
Q2 2024 Aug 14, 2024	BUY	$4.33 - $6.79 $8.97 Million - $14.1 Million	2,071,068 Added 103.52%	4,071,677 $20 Million
Q1 2024 May 15, 2024	BUY	$4.03 - $7.81 $2,454 - $4,756	609 Added 0.03%	2,000,609 $14.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $873,085 - $2.48 Million	535,635 Added 36.58%	2,000,000 $9.08 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $1.62 Million - $2.92 Million	759,742 Added 107.82%	1,464,365 $3.46 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $327,912 - $994,669	156,149 Added 28.47%	704,623 $2.48 Million
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $1.39 Million - $2.78 Million	372,824 Added 212.25%	548,474 $2.11 Million
Q4 2022 Feb 14, 2023	SELL	$4.56 - $6.61 $4.95 Million - $7.18 Million	-1,086,120 Reduced 86.08%	175,650 $908,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $6.63 $3.2 Million - $5.65 Million	852,140 Added 208.03%	1,261,770 $7.8 Million
Q2 2022 Aug 15, 2022	BUY	$2.11 - $4.06 $864,319 - $1.66 Million	409,630 New	409,630 $1.54 Million
Q4 2020 Feb 16, 2021	SELL	$20.81 - $30.55 $4.18 Million - $6.13 Million	-200,738 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.5 - $30.23 $3.51 Million - $6.07 Million	200,738 New	200,738 $6.07 Million

Others Institutions Holding ANNX

# of Institutions

146

Shares Held

102M

Call Options Held

178K

Put Options Held

159K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $260M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Annexon, Inc. Transaction History